• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由设计的模板配体诱导的p53-R337H突变体四聚化结构域的稳定性和结构恢复

Stability and structural recovery of the tetramerization domain of p53-R337H mutant induced by a designed templating ligand.

作者信息

Gordo Susana, Martos Vera, Santos Eva, Menéndez Margarita, Bo Carles, Giralt Ernest, de Mendoza Javier

机构信息

Institute for Research in Biomedicine, Parc Científic de Barcelona, Baldiri Reixac, 10, 08028 Barcelona, Spain.

出版信息

Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16426-31. doi: 10.1073/pnas.0805658105. Epub 2008 Oct 21.

DOI:10.1073/pnas.0805658105
PMID:18940924
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2575436/
Abstract

Protein p53 is a transcription factor crucial for cell cycle and genome integrity. It is able to induce both cell arrest when DNA is damaged and the expression of DNA repair machinery. When the damage is irreversible, it triggers apoptosis. Indeed, the protein, which is a homotetramer, is mutated in most human cancers. For instance, the inherited mutation p53-R337H results in destabilization of the tetramer and, consequently, leads to an organism prone to tumor setup. We describe herein a rational designed molecule capable of holding together the four monomers of the mutated p53-R337H protein, recovering the tetramer integrity as in the wild-type structure. Two ligand molecules, based on a conical calix[4]arene with four cationic guanidiniomethyl groups at the wider edge (upper rim) and hydrophobic loops at the narrower edge (lower rim), fit nicely and cooperatively into the hydrophobic clefts between two of the monomers at each side of the protein and keep the tetrameric structure, like molecular templates, by both ion-pair and hydrophobic interactions. We found a good agreement between the structure of the complex and the nature of the interactions involved by a combination of theory (molecular dynamics) and experiments (circular dichroism, differential scanning calorimetry and (1)H saturation transfer difference NMR).

摘要

蛋白质p53是一种对细胞周期和基因组完整性至关重要的转录因子。当DNA受损时,它能够诱导细胞停滞并促进DNA修复机制的表达。当损伤不可逆转时,它会触发细胞凋亡。实际上,这种作为同四聚体的蛋白质在大多数人类癌症中都发生了突变。例如,遗传性突变p53-R337H会导致四聚体不稳定,从而使生物体易于形成肿瘤。我们在此描述了一种经过合理设计的分子,它能够将突变型p53-R337H蛋白的四个单体结合在一起,恢复野生型结构中的四聚体完整性。两种配体分子基于一种在较宽边缘(上缘)带有四个阳离子胍基甲基基团且在较窄边缘(下缘)带有疏水环的锥形杯[4]芳烃,它们很好地且协同地嵌入到蛋白质两侧两个单体之间的疏水裂缝中,并通过离子对和疏水相互作用像分子模板一样保持四聚体结构。我们通过理论(分子动力学)和实验(圆二色性、差示扫描量热法和1H饱和转移差分核磁共振)相结合的方法,发现复合物的结构与所涉及相互作用的性质之间具有良好的一致性。

相似文献

1
Stability and structural recovery of the tetramerization domain of p53-R337H mutant induced by a designed templating ligand.由设计的模板配体诱导的p53-R337H突变体四聚化结构域的稳定性和结构恢复
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16426-31. doi: 10.1073/pnas.0805658105. Epub 2008 Oct 21.
2
On the role of flexibility in protein-ligand interactions: the example of p53 tetramerization domain.在蛋白质-配体相互作用中灵活性的作用:以 p53 四聚化结构域为例。
Chem Asian J. 2011 Jun 6;6(6):1463-9. doi: 10.1002/asia.201000938.
3
Mechanistic insight into the destabilization of p53TD tetramer by cancer-related R337H mutation: a molecular dynamics study.探究癌症相关 R337H 突变导致 p53TD 四聚体不稳定的机制:分子动力学研究。
Phys Chem Chem Phys. 2022 Feb 23;24(8):5199-5210. doi: 10.1039/d1cp05670k.
4
A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer.一种涉及突变型p53四聚体pH依赖性去稳定化的肿瘤发生新机制。
Nat Struct Biol. 2002 Jan;9(1):12-6. doi: 10.1038/nsb730.
5
Enhancement of transcriptional activity of mutant p53 tumor suppressor protein through stabilization of tetramer formation by calix[6]arene derivatives.通过杯[6]芳烃衍生物稳定四聚体形成来增强突变型 p53 肿瘤抑制蛋白的转录活性。
Bioorg Med Chem Lett. 2010 Aug 1;20(15):4412-5. doi: 10.1016/j.bmcl.2010.06.053. Epub 2010 Jun 15.
6
Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant.p53四聚化结构域及一种癌症相关突变体导致的可逆性淀粉样蛋白形成
J Mol Biol. 2003 Mar 28;327(3):699-709. doi: 10.1016/s0022-2836(03)00175-x.
7
Tandem dimerization of the human p53 tetramerization domain stabilizes a primary dimer intermediate and dramatically enhances its oligomeric stability.人p53四聚化结构域的串联二聚化稳定了初级二聚体中间体,并显著增强了其寡聚稳定性。
J Mol Biol. 2007 Jan 26;365(4):1217-31. doi: 10.1016/j.jmb.2006.10.051. Epub 2006 Oct 21.
8
Cancer-associated p53 tetramerization domain mutants: quantitative analysis reveals a low threshold for tumor suppressor inactivation.癌相关 p53 四聚化结构域突变体:定量分析揭示了肿瘤抑制子失活的低阈值。
J Biol Chem. 2011 Jan 7;286(1):252-8. doi: 10.1074/jbc.M110.174698. Epub 2010 Oct 26.
9
Disruption of an intermonomer salt bridge in the p53 tetramerization domain results in an increased propensity to form amyloid fibrils.p53四聚化结构域中单体间盐桥的破坏导致形成淀粉样原纤维的倾向增加。
Protein Sci. 2005 Dec;14(12):2993-3003. doi: 10.1110/ps.051622005. Epub 2005 Oct 31.
10
A fluid salt-bridging cluster and the stabilization of p53.一种流体盐桥簇与p53的稳定性
J Mol Biol. 2007 Nov 9;373(5):1334-47. doi: 10.1016/j.jmb.2007.07.080. Epub 2007 Aug 24.

引用本文的文献

1
How Do Cancer-Related Mutations Affect the Oligomerisation State of the p53 Tetramerisation Domain?癌症相关突变如何影响p53四聚化结构域的寡聚化状态?
Curr Issues Mol Biol. 2023 Jun 7;45(6):4985-5004. doi: 10.3390/cimb45060317.
2
Complex Formation between Cytochrome and a Tetra-alanino-calix[4]arene.细胞色素与四丙氨酸杯[4]芳烃的配合物形成。
Int J Mol Sci. 2022 Dec 6;23(23):15391. doi: 10.3390/ijms232315391.
3
Structural Basis of Mutation-Dependent p53 Tetramerization Deficiency.突变依赖的 p53 四聚体缺陷的结构基础。
Int J Mol Sci. 2022 Jul 19;23(14):7960. doi: 10.3390/ijms23147960.
4
Protein-Calixarene Complexation: From Recognition to Assembly.蛋白质-杯芳烃络合:从识别到组装。
Acc Chem Res. 2022 Aug 2;55(15):2019-2032. doi: 10.1021/acs.accounts.2c00206. Epub 2022 Jun 6.
5
NMR Spectroscopy of supramolecular chemistry on protein surfaces.蛋白质表面超分子化学的核磁共振光谱学
Beilstein J Org Chem. 2020 Oct 9;16:2505-2522. doi: 10.3762/bjoc.16.203. eCollection 2020.
6
p53 tetramerization: at the center of the dominant-negative effect of mutant p53.p53 四聚体化:突变型 p53 显性负效应的中心。
Genes Dev. 2020 Sep 1;34(17-18):1128-1146. doi: 10.1101/gad.340976.120.
7
Atomic Details of Carbon-Based Nanomolecules Interacting with Proteins.碳基纳米分子与蛋白质相互作用的原子细节。
Molecules. 2020 Aug 4;25(15):3555. doi: 10.3390/molecules25153555.
8
Calix[4]API-s: fully functionalized calix[4]arene-based facial active pharmaceutical ingredients.杯[4]芳烃类活性药物成分:基于杯[4]芳烃的全功能化面式活性药物成分。
Mol Divers. 2021 May;25(2):1247-1258. doi: 10.1007/s11030-020-10042-0. Epub 2020 Jan 31.
9
Macrocyclic Compounds for Drug and Gene Delivery in Immune-Modulating Therapy.用于免疫调节治疗的药物和基因递送的大环化合物。
Int J Mol Sci. 2019 Apr 28;20(9):2097. doi: 10.3390/ijms20092097.
10
Supramolecular Chemistry Targeting Proteins.超分子化学靶向蛋白质。
J Am Chem Soc. 2017 Oct 11;139(40):13960-13968. doi: 10.1021/jacs.7b01979. Epub 2017 Sep 28.

本文引用的文献

1
Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors.生物系统中的多价相互作用:对多价配体和抑制剂设计与应用的启示
Angew Chem Int Ed Engl. 1998 Nov 2;37(20):2754-2794. doi: 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3.
2
Amine-guanidine switch: a promising approach to improve DNA binding and antiproliferative activities.胺-胍转换:一种改善DNA结合和抗增殖活性的有前景的方法。
J Med Chem. 2007 Dec 27;50(26):6465-75. doi: 10.1021/jm701207m. Epub 2007 Dec 4.
3
Temperature dependence of ligand-protein complex formation as reflected by saturation transfer difference NMR experiments.通过饱和转移差异核磁共振实验反映的配体 - 蛋白质复合物形成的温度依赖性。
Magn Reson Chem. 2007 Sep;45(9):745-8. doi: 10.1002/mrc.2041.
4
Structure-function-rescue: the diverse nature of common p53 cancer mutants.结构-功能挽救:常见p53癌症突变体的多样性质
Oncogene. 2007 Apr 2;26(15):2226-42. doi: 10.1038/sj.onc.1210291.
5
Strategies to search and design stabilizers of protein-protein interactions: a feasibility study.蛋白质-蛋白质相互作用稳定剂的搜索与设计策略:一项可行性研究。
Proteins. 2007 Jul 1;68(1):170-86. doi: 10.1002/prot.21296.
6
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.突变型p53功能特性对TP53突变模式和肿瘤表型的影响:来自国际癌症研究机构TP53数据库最新进展的经验教训
Hum Mutat. 2007 Jun;28(6):622-9. doi: 10.1002/humu.20495.
7
The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.TP53基因的R337H突变与巴西家族中的李-佛美尼综合征及李-佛美尼样综合征相关。
Cancer Lett. 2007 Jan 8;245(1-2):96-102. doi: 10.1016/j.canlet.2005.12.039. Epub 2006 Feb 21.
8
Unfolding, aggregation, and amyloid formation by the tetramerization domain from mutant p53 associated with lung cancer.与肺癌相关的突变型p53四聚化结构域的解折叠、聚集及淀粉样蛋白形成
Biochemistry. 2006 Feb 14;45(6):1608-19. doi: 10.1021/bi051192j.
9
Targeting protein-protein interactions for cancer therapy.以蛋白质-蛋白质相互作用为靶点进行癌症治疗。
J Mol Med (Berl). 2005 Dec;83(12):955-63. doi: 10.1007/s00109-005-0705-x. Epub 2005 Nov 11.
10
GROMACS: fast, flexible, and free.GROMACS:快速、灵活且免费。
J Comput Chem. 2005 Dec;26(16):1701-18. doi: 10.1002/jcc.20291.